COSCIENS Biopharma Inc.【CSCIF】

Market cap

$87.12M

P/E ratio

	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents (note 7)	8	15	8	24	65	51	34	16
Trade and other receivables (note 8)	0	0	1	2	1	1	0	2
Inventories (note 9)	-	-	-	-	-	-	0	3
Income taxes receivable	-	-	-	-	2	1	0	0
Prepaid expenses and other assets (note 10)	1	1	1	2	2	2	2	2
Total current assets	9	16	11	28	71	55	36	24
Restricted cash and cash equivalents (note 7)	0	0	0	0	0	0	0	0
Property and equipment (note 11)	0	0	0	0	0	0	0	11
Intangible assets (note 12)	0	0	0	0	1	-	-	-
Deferred tax assets (note 21)	-	-	-	-	1	1	0	-
Total non-current assets	-	-	-	-	-	1	1	11
Total assets	22	25	20	37	80	56	37	35
Payables and accrued liabilities (note 13)	-	-	-	-	-	4	4	5
Provisions	-	-	-	-	-	0	-	0
Income taxes payable	-	2	1	0	0	0	0	0
Current portion of deferred revenues (note 6)	-	-	-	-	-	-	0	0
Current portion of lease liabilities (note 14)	-	-	1	0	0	0	0	0
Warrant liability (note 16)	-	-	-	-	-	-	-	2
DSU liability (note 17)	-	-	-	-	-	-	-	0
Total current liabilities	6	6	6	5	8	7	5	7
Deferred revenues (note 6)	-	-	-	-	-	-	2	1
Lease liabilities (note 14)	-	-	0	0	0	0	0	2
Employee future benefits (note 15)	14	13	14	15	17	11	13	12
Total non-current liabilities	-	-	-	-	-	13	14	15
Total liabilities	25	23	22	24	27	20	19	22
Share capital (note 18)	222	222	225	235	293	293	293	22
Contributed surplus (note 18)	-	-	-	-	-	-	91	4
Retained earnings (accumulated deficit)	-314	-310	-317	-323	-335	-352	-370	-12
Accumulated other comprehensive loss	0	0	0	-1	-1	-1	-1	-1
Total shareholders’ equity	-3	2	-2	13	53	36	18	13
Total liabilities and shareholders’ equity	22	25	20	37	80	56	37	35